Piramal Pharma Solutions (PPS), a part of Piramal Pharma Ltd, has announced an $80 million investment plan to expand its Lexington, Kentucky facility. The company stated that this site specialises in sterile compounding, liquid filling, and lyophilisation for sterile injectable drug products, playing a crucial role in the company’s integrated antibody-drug conjugate (ADC) development and …